Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections (CROI) Boston, Massachusetts March 4-7, 2018 Back

Antiviral Activity of Tenofovir Alafenamide Against HIV-1 with Thymidine Analog Mutation(s) and M184V         Reported by Jules Levin CROI 2018 March 4-7 Boston, MA   Na Margot, RR Ram, ME Abram, R Haubrich, C Callebaut Gilead Sciences, Inc., Foster City, CA   HIV Dart/2016: Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog Mutation(s) and M184V - (12/15/16)   Antiviral Activity of Tenofovir Alafenamide (TAF) against Major NRTI-Resistant Viruses: Improvement over TDF/TFV is Driven by Higher TFV-DP Loading in Target cells (06/09/13)